
    
      This first-in-human study will be carried out in one study center involving multiple steps.
      Up to 100 healthy male and female subjects will be enrolled. The study consists of 4 parts:

        1. a single ascending dose (SAD) part

        2. a multiple ascending dose (MAD) part

        3. a single dose, double cross-over food effect (FE) part.

        4. a single dose gender effect part (female subjects group) The safety and PK data will be
           evaluated by the DSMC after each cohort to decide on further dose escalation.
    
  